Perrigo (PRGO) Exchange Rate Effect (2013 - 2026)
Perrigo's (PRGO) quarterly Exchange Rate Effect came in at -$3.1 million in Q1 2026, down 130.1% year-on-year from $10.3 million in Q1 2025, and down 203.33% on a QoQ basis from $3.0 million in Q4 2025.
Perrigo (PRGO) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Exchange Rate Effect data on file, last reported at -$3.1 million in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 130.1% year-over-year to -$3.1 million in Q1 2026; TTM through Mar 2026 was $19.1 million, a 453.7% increase from a year earlier, with the FY2025 full-year figure at $32.5 million, up 240.09% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$3.1 million, down from $3.0 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for PRGO reached as high as $19.0 million in Q2 2025 and fell as low as -$47.9 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$1.9 million across 5 years, with a median of $200000.0 in 2025.
- Across the five-year window, Exchange Rate Effect tumbled 6942.86% in 2022 and soared 1004.76% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $14.6 million in 2022, then fell by 19.86% to $11.7 million in 2023, then slumped by 323.08% to -$26.1 million in 2024, then surged by 111.49% to $3.0 million in 2025, then plunged by 203.33% to -$3.1 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$3.1 million in Q1 2026, $3.0 million in Q4 2025, and $200000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -3.10 Mn |
| Mar 28, 2026 | -3.10 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 27, 2025 | 200,000.00 |
| Sep 27, 2025 | 200,000.00 |
| Jun 28, 2025 | 19.00 Mn |
| Jun 28, 2025 | 19.00 Mn |
| Mar 29, 2025 | 10.30 Mn |
| Mar 29, 2025 | 10.30 Mn |
| Dec 31, 2024 | -26.10 Mn |
| Dec 31, 2024 | -26.10 Mn |
| Sep 28, 2024 | 12.50 Mn |
| Sep 28, 2024 | 12.50 Mn |
| Jun 29, 2024 | -2.10 Mn |
| Jun 29, 2024 | -2.10 Mn |
| Mar 30, 2024 | -7.50 Mn |
| Mar 30, 2024 | -7.50 Mn |
| Dec 31, 2023 | 11.70 Mn |
| Dec 31, 2023 | 11.70 Mn |